ExThera, a company based outside of Oakland, California, won European regulatory approval for its Seraph 100 Microbind Affinity Blood Filter.
The device removes a variety of pathogens in patients with bloodstream infections thanks to its “sorbent-type” filter. It can remove not only molecular compounds, such as cytokines and en (Read more...)